Home > Press > Science and Society - Next Show
Science and Society - Next Show
Dr. David Lemberg
Host - Science and Society
San Diego, CA | August 16, 2005
Dr. David Lemberg, Executive Producer of "Science and Society" - http://www.scienceandsociety.net - announces the show schedule for Wednesday, 8/24/05, 1PM to 2PM Pacific.
Of particular interest to Nanotechnology Now readers is the interview with:
- Dr. Billy J. Stanbery.
While at the University of Washington, Dr. Stanbery was a Research Assistant for Professor Martin Gouterman's Laboratory of Porphyrin Electro-Optics, where he devised experimental strategies and designed experimental equipment for the study of the optical and electronic properties of thin-film photovoltaics fabricated from organic dye compounds.
In 2001, Dr. Stanbery founded HelioVolt Corporation in order to develop and market new technology for applying thin-film photovoltaic coatings to conventional construction materials. He invented the company’s proprietary FASST™ process, a low-cost, flexible manufacturing process for CIGS synthesis. FASST™ is protected by both eight issued U.S. patents and global patents pending.
####
"Science and Society" is a public service of The Hopkins Capital Group www.hopkinscap.com
Media Contact:
David Lemberg
davidlemberg@earthlink.net
Copyright ©
Science and Society
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Innovative sensing platform unlocks ultrahigh sensitivity in conventional sensors: Lan Yang and her team have developed new plug-and-play hardware to dramatically enhance the sensitivity of optical sensors April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
A simple, inexpensive way to make carbon atoms bind together: A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules, which are critical for drug development April 5th, 2024